AAMU
BIVV

Amundi Asset Management US’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Amundi Asset Management US’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,755
Closed -$903K – 1632
2017
Q4 		$903K Buy
+16,755
New +$917K ﹤0.01% 1219

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Amundi Asset Management US's BIVV Position: Q1 2018 in Review

Amundi Asset Management US sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 16,755 shares — an estimated $903K sold.

Amundi Asset Management US first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $903K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Amundi Asset Management US reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 16,755 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $903K.
  • Amundi Asset Management US first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Amundi Asset Management US's Bioverativ Inc. Common Stock position peaked at $903K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Amundi Asset Management US's 13F filing for Q1 2018, filed 15 May 2018.